Dolatrai Vyas - 21 Jun 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Reporting relationship: Former Director
Issuer ticker: N/A
Reported as of: 21 Jun 2022
Net transaction value: -$3,362
SEC form: 4
Accepted by SEC: 22 Jun 2022, 21:45:11 UTC
Prior SEC filing: 22 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Keith M. McGahan, attorney-in-fact for Dolatrai Vyas

Key filing fact

Dolatrai Vyas filed Form 4 for SPECTRUM PHARMACEUTICALS INC on 22 Jun 2022.

Key facts

This page summarizes Dolatrai Vyas's Form 4 filing for SPECTRUM PHARMACEUTICALS INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2022, 21:45.

Change

Previous filing in this sequence was filed on 22 Jun 2021.
Current net transaction value: -$3,362.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPPI transaction

Common Stock, $0.001 par value

Sale

Transaction value: $3,362
Shares: -4,283
Change %: -5%
Price: $0.7850
Shares after: 82,063
Date: 21 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.